Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices deli… Read more
Creo Medical Group PLC (CREO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.256x
Based on the latest financial reports, Creo Medical Group PLC (CREO) has a cash flow conversion efficiency ratio of 0.256x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX15.60 Million) by net assets (GBX60.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Creo Medical Group PLC - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Creo Medical Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Creo Medical Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Creo Medical Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UNI-PRESIDENT CHINA (58U.SG)
STU:58U
|
N/A |
|
Voyager Digital Ltd
PINK:VYGVQ
|
-0.047x |
|
N.W.F Group
LSE:NWF
|
0.102x |
|
Nexa Resources Peru S.A.A.
LIM:NEXAPEC1
|
N/A |
|
LIONTOWN
BE:LIS
|
N/A |
|
Dawood Hercules Corporation Ltd
KAR:DAWH
|
-0.025x |
|
KAROON GAS AUST
BE:LBL
|
N/A |
|
MJardin Group Inc
PINK:MJARF
|
0.018x |
Annual Cash Flow Conversion Efficiency for Creo Medical Group PLC (2014–2024)
The table below shows the annual cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX42.40 Million | GBX-22.20 Million | -0.524x | -44.96% |
| 2023-12-31 | GBX59.80 Million | GBX-21.60 Million | -0.361x | +28.59% |
| 2022-12-31 | GBX49.40 Million | GBX-24.99 Million | -0.506x | -42.74% |
| 2021-12-31 | GBX73.32 Million | GBX-25.98 Million | -0.354x | -38.36% |
| 2020-12-31 | GBX62.81 Million | GBX-16.09 Million | -0.256x | -83.44% |
| 2019-12-31 | GBX82.66 Million | GBX-11.54 Million | -0.140x | +53.07% |
| 2018-12-31 | GBX47.71 Million | GBX-14.20 Million | -0.298x | +68.83% |
| 2018-06-30 | GBX7.33 Million | GBX-7.00 Million | -0.955x | -102.27% |
| 2017-06-30 | GBX14.65 Million | GBX-6.91 Million | -0.472x | +53.13% |
| 2016-06-30 | GBX1.63 Million | GBX-1.64 Million | -1.007x | -3.79% |
| 2016-02-29 | GBX3.22 Million | GBX-3.13 Million | -0.970x | +68.09% |
| 2015-02-28 | GBX748.41K | GBX-2.27 Million | -3.040x | -206.94% |
| 2014-02-28 | GBX1.37 Million | GBX-1.36 Million | -0.990x | -- |